NLRP1 is considered to be a tumor suppressor, but aberrant NLRP1 inflammasome activation due to gain-of-function mutations has been associated with cancers and autoimmune diseases [11,40,41], which could reasonably explain why some melanoma cell lines, if not all, are capable of secreting IL-1β. Here, IL1B is linked to melanoma.